Pediatric Gastroenteropancreatic Neuroendocrine Tumors in Jordan: A 19-Year Experience From a Tertiary Oncology Center.

IF 0.9 4区 医学 Q4 HEMATOLOGY
Dana Kanaan, Khalil Ghandour, Maha Barbar, Iyad Sultan, Hadeel Halalsheh
{"title":"Pediatric Gastroenteropancreatic Neuroendocrine Tumors in Jordan: A 19-Year Experience From a Tertiary Oncology Center.","authors":"Dana Kanaan, Khalil Ghandour, Maha Barbar, Iyad Sultan, Hadeel Halalsheh","doi":"10.1097/MPH.0000000000003273","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pediatric gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are exceedingly rare. Data from Jordanian and Arab world populations are absent from international registries, with only limited data available from Türkiye, leaving management strategies largely extrapolated from adult and Western literature. This study documents the clinical features, management, and outcomes at a tertiary oncology center in Jordan.</p><p><strong>Methods: </strong>We conducted a retrospective, single-center cohort study of patients 18 years or younger diagnosed with GEP-NETs at the King Hussein Cancer Center (January 2006 to May 2025). We analyzed demographics, presentation, tumor characteristics, treatment, and survival.</p><p><strong>Results: </strong>Ten patients were identified (8 male, median age 13 y). Primary sites were the appendix (8/10) and pancreatic head (2/10). Nine patients presented with abdominal pain; one with a pancreatic primary presented with obstructive jaundice. Histologically, 9 were low- or intermediate-grade (grade 1 to 2) and 9 were localized. Nine patients underwent surgery (8 appendectomy±hemicolectomy; 1 Whipple procedure). One patient with metastatic pancreatic NET was managed nonsurgically. Two patients with advanced/metastatic pancreatic NETs received systemic therapy. Appendiceal tumors were universally indolent with excellent outcomes postsurgery, whereas pancreatic tumors exhibited aggressive clinical behavior, including nodal involvement and distant metastasis. After a median follow-up of 46.6 months, 1 patient died of metastatic disease and 1 developed recurrence; both had pancreatic primaries.</p><p><strong>Conclusions: </strong>Pediatric appendiceal NETs carry excellent prognoses following conservative surgery. Pancreatic NETs represent a high-risk subgroup with aggressive behavior. As the first documented GEP-NET from Jordan and the Arab world, these findings align with international patterns and support site-specific, risk-adapted management while highlighting the need for multicenter collaboration across the region.</p>","PeriodicalId":16693,"journal":{"name":"Journal of Pediatric Hematology/Oncology","volume":" ","pages":"406-411"},"PeriodicalIF":0.9000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Hematology/Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MPH.0000000000003273","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/15 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pediatric gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are exceedingly rare. Data from Jordanian and Arab world populations are absent from international registries, with only limited data available from Türkiye, leaving management strategies largely extrapolated from adult and Western literature. This study documents the clinical features, management, and outcomes at a tertiary oncology center in Jordan.

Methods: We conducted a retrospective, single-center cohort study of patients 18 years or younger diagnosed with GEP-NETs at the King Hussein Cancer Center (January 2006 to May 2025). We analyzed demographics, presentation, tumor characteristics, treatment, and survival.

Results: Ten patients were identified (8 male, median age 13 y). Primary sites were the appendix (8/10) and pancreatic head (2/10). Nine patients presented with abdominal pain; one with a pancreatic primary presented with obstructive jaundice. Histologically, 9 were low- or intermediate-grade (grade 1 to 2) and 9 were localized. Nine patients underwent surgery (8 appendectomy±hemicolectomy; 1 Whipple procedure). One patient with metastatic pancreatic NET was managed nonsurgically. Two patients with advanced/metastatic pancreatic NETs received systemic therapy. Appendiceal tumors were universally indolent with excellent outcomes postsurgery, whereas pancreatic tumors exhibited aggressive clinical behavior, including nodal involvement and distant metastasis. After a median follow-up of 46.6 months, 1 patient died of metastatic disease and 1 developed recurrence; both had pancreatic primaries.

Conclusions: Pediatric appendiceal NETs carry excellent prognoses following conservative surgery. Pancreatic NETs represent a high-risk subgroup with aggressive behavior. As the first documented GEP-NET from Jordan and the Arab world, these findings align with international patterns and support site-specific, risk-adapted management while highlighting the need for multicenter collaboration across the region.

约旦儿童胃肠胰腺神经内分泌肿瘤:来自三级肿瘤中心的19年经验。
背景:小儿胃肠胰神经内分泌肿瘤(GEP-NETs)极为罕见。国际登记中没有约旦和阿拉伯世界人口的数据,只有 rkiye提供的有限数据,使得管理策略主要从成人和西方文献中推断出来。本研究记录了约旦一家三级肿瘤中心的临床特征、管理和结果。方法:我们对侯赛因国王癌症中心(2006年1月至2025年5月)18岁及以下诊断为GEP-NETs的患者进行了一项回顾性、单中心队列研究。我们分析了人口统计学、表现、肿瘤特征、治疗和生存率。结果:10例确诊患者(男性8例,中位年龄13岁)。主要部位为阑尾(8/10)和胰头(2/10)。9例患者出现腹痛;原发性胰脏患者表现为梗阻性黄疸。组织学上,9例为低度或中度(1至2级),9例为局限性。9例患者接受手术治疗(阑尾切除术+结肠切除术8例;Whipple手术1例)。一例转移性胰腺NET患者采用非手术治疗。2例晚期/转移性胰腺NETs患者接受了全身治疗。阑尾肿瘤普遍表现为惰性,术后预后良好,而胰腺肿瘤表现为侵袭性临床行为,包括淋巴结累及和远处转移。中位随访46.6个月后,1例患者死于转移性疾病,1例复发;两人都有胰腺原发。结论:小儿阑尾NETs在保守手术后预后良好。胰腺NETs是具有攻击性行为的高危亚群。作为约旦和阿拉伯世界首次记录的全球环境网络,这些发现与国际模式一致,支持针对特定地点的风险适应管理,同时强调需要在整个地区开展多中心合作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
8.30%
发文量
415
审稿时长
2.5 months
期刊介绍: ​Journal of Pediatric Hematology/Oncology (JPHO) reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. The journal publishes original research, commentaries, historical insights, and clinical and laboratory observations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书